Prostate Cancer VL

From Blood to Diagnosis: the Role of ctDNA in Prostate Cancer Treatment - Alexander Wyatt

Details
In this discussion between Alicia Morgans and Alexander Wyatt, the two delve into the complexities of using circulating tumor DNA (ctDNA) in the treatment of prostate cancer. Dr. Wyatt explains the advantages of ctDNA in the metastatic setting, highlighting its minimally invasive nature and ease of collection compared to tissue biopsy. He emphasizes the importance of timing and patient selection i...

Exploring Molecular Drivers and Predictive Biomarkers of Prostate Cancer Heterogeneity - Marzia Del Re

Details
Marzia Del Re discusses the complexity of tumor heterogeneity in prostate cancer, focusing on predictive biomarkers of resistance and response to therapy. Dr. Del Re emphasizes the high heterogeneity of prostate cancer from clinical, morphological, and molecular perspectives, highlighting the role of genetic and epigenetic alterations. She explores technological advancements like next-generation s...

The Role of Tumor Immune Response in Castration-Resistant Prostate Cancer - Andrea Alimonti

Details
Andrea Alimonti discusses the challenges and advancements in the understanding and treatment of castration-resistant prostate cancer (CRPC). Dr. Alimonti highlights his team's efforts to comprehend the mechanisms of CRPC initiation and progression and explores potential therapies that could reverse or treat CRPC using anti-tumor immune responses. He emphasizes his team's contributions to the field...

The Ups and Downs of One Man's Prostate Cancer Battle - Julio Pelaitai

Details
Julio Pelaitai recounts his journey with prostate cancer, which began with a surprise diagnosis following regular checkups. Initially, his prostate appeared healthy, but a subsequent rise in PSA levels led to a biopsy revealing high-grade malignant cells. Faced with options of surgery, radiation, or chemotherapy, Julio chose surgery, guided by his urologist. Post-surgery, elevated PSA levels indic...

Exercise and Activity Aids Man’s Recovery and Outlook After Prostate Cancer - Ignacio Calderón Balanzátegui

Details
Ignacio Calderón Balanzátegui shares his experience with prostate cancer, diagnosed three years ago at the age of 72. He underwent rapid surgery to remove his prostate, followed by minimal chemotherapy, as the cancer was caught early and had only slightly metastasized. Ignacio credits his prompt diagnosis and treatment to regular check-ups for his diabetes, which unexpectedly revealed a high PSA l...

Advances in Precision Medicine Rapidly Transforming Treatment Options for Bladder Cancer Patients - Daniel Castellano

Details
Daniel Castellano emphasizes the importance of multidisciplinary approaches in patient care and research. He advocates for precision medicine in genitourinary tumors, highlighting advancements in prostate and bladder cancer treatments. Dr. Castellano stresses the need to overcome barriers in drug access and regulatory processes to provide better care. He expresses a strong connection with Argentin...

Female Oncologist Bridges Divide in Male-Dominated Urology Field - Gabriela Gatica

Details
Gabriela Gatica discusses her experience as a woman in the male-dominated field of uro-oncology. Initially facing skepticism about working with male urologists and treating predominantly male patients, she found acceptance and success in her role. Dr. Gatica emphasizes the positive dynamics of interdisciplinary teamwork and encourages more women to join this fascinating specialty, aiming to increa...

Interdisciplinary Uro-Oncology Conference Convenes in Mendoza - Mauricio Fernández Lázaro

Details
Mauricio Fernández Lázaro discusses UroTarget, an annual conference in Mendoza that focuses on the interdisciplinary management of uro-oncological pathologies. The location fosters social interactions and networking among professionals, extending beyond scientific discussions to build friendships and strengthen interdisciplinary relations. Biographies: Mauricio Fernández Lázaro, MD Related Content...

The Evolving Role of Urology in Multidisciplinary Cancer Care Teams - Gustavo Villoldo

Details
Gustavo Villoldo emphasizes the crucial role of urological surgery within multidisciplinary teams in uro-oncology, highlighting its unique positioning amid perioperative treatments and the technological advancements that have improved patient care. He discusses the challenges of adopting new technologies in Latin America, particularly in Argentina, where access to high-tech surgeries is limited by...

UroTarget Conference: Driving Advances in Multidisciplinary Uro-Oncology Care in Latin America - Cecilia Atencio

Details
Cecilia Atencio reflects on her journey with UroTarget, a multidisciplinary conference that evolved from a local gathering into an international event, paralleling the advancements in radiotherapy within Mendoza, from 3D-CRT to the cutting-edge IGRT and radiosurgery. She highlights the conference's role in fostering education, encouraging the integration of young professionals and women into uro-o...